Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia
Default Network Dysfunction Underlying Visuospatial Attention Deficits in Schizophrenia
2 other identifiers
observational
64
1 country
1
Brief Summary
Background: \- A special brain circuit is important for helping us keeping an eye open for things that are going on around us, even when we are not directly paying attention to them. This circuit seems to work differently in people with schizophrenia than in other people, which may explain specific deficits with broad monitoring observed in people with schizophrenia. Researchers want to compare brain function in people with schizophrenia and healthy volunteers to find out more about how these brain circuits work and affect attention. Objectives: \- To study how the brain performs broad visual monitoring in people with schizophrenia. Eligibility:
- Individuals between 18 to 55 years of age who have been diagnosed with schizophrenia.
- Healthy volunteers between 18 and 55. Design:
- Participants will be screened with physical and psychological exams. They will have a medical history. Tests for drug and alcohol use will also be done.
- Participants will have two study visits. The first is a training visit and the second is a scanning visit.
- At the training visit, participants will practice computer-based tests of focus, memory, and concentration. They will also answer questions about mood, psychiatric symptoms, and smoking habits.
- At the scanning visit, participants will perform the computer-based tasks that they practiced at the training visit. They will have magnetic resonance imaging while they perform these tasks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 3, 2011
CompletedFirst Submitted
Initial submission to the registry
July 20, 2011
CompletedFirst Posted
Study publicly available on registry
July 21, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2014
CompletedApril 5, 2018
December 24, 2014
July 20, 2011
April 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Behavioral performance measures on the cognitive tasks (e.g. reaction time, accuracy)
Bold signal, specifically activation of the default network of resting brain function and its association with task performance.
Secondary Outcomes (1)
Secondary outcome measures include ratings and scores on questionnaires and characterization tools.
Eligibility Criteria
You may qualify if:
- All participants:
- Age 18 through 55.
- Normal or corrected to normal visual acuity (at least 20/80)
- Participants with menat illness:
- DSM-IV diagnosis of schizophrenia or schizoaffective disorder
- Ability to give written informed consent
- Four week of stable pharmacological treatment (same psychiatric medication at same dose or no medication)
You may not qualify if:
- All participants:
- Presence of ferromagnetic metal objects in the body, implanted electronic devices or any other counter -indication for MRI.
- Claustrophobia
- Left handed or ambidextrous
- History of myocardial infarction or heart failur, which may cause asymptomatic brain lesions
- Uncontrolled high blood pressure (resting systolic greater than 150 or diastolic greater than 90 mm Hg)
- Neurological conditions likely to impair cognitive function such as stroke, seizures, dementia or organic brian syndrome
- Any condition likely to impair cognitive function such as mental retardation or severe pharmacological sedation
- Current use of vasodilating beta-blockers (carvedilol, labetalol or nebivolol)
- Alcohol or substance abuse or dependence other than nicotine within the last 6 months
- Pregnancy, verified by urin pregnancy test for females during screening and on the day of the scan.
- Healthy Controls:
- Current psychiatric Axis I disorder or Axis II schizophrenia spectrum disorder, verified by Structured Clinical Interview for DSM-IV (SCID)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maryland Psychiatric Research Center (MPRC) 55 Wade Avenue
Catonsville, Maryland, 21228, United States
Related Publications (3)
Binder JR, Frost JA, Hammeke TA, Bellgowan PS, Rao SM, Cox RW. Conceptual processing during the conscious resting state. A functional MRI study. J Cogn Neurosci. 1999 Jan;11(1):80-95. doi: 10.1162/089892999563265.
PMID: 9950716BACKGROUNDBuckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008 Mar;1124:1-38. doi: 10.1196/annals.1440.011.
PMID: 18400922BACKGROUNDBustillo JR, Thaker G, Buchanan RW, Moran M, Kirkpatrick B, Carpenter WT Jr. Visual information-processing impairments in deficit and nondeficit schizophrenia. Am J Psychiatry. 1997 May;154(5):647-54. doi: 10.1176/ajp.154.5.647.
PMID: 9137120BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elliot Stein, Ph.D.
National Institute on Drug Abuse (NIDA)
Study Design
- Study Type
- observational
- Time Perspective
- OTHER
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2011
First Posted
July 21, 2011
Study Start
July 3, 2011
Study Completion
December 24, 2014
Last Updated
April 5, 2018
Record last verified: 2014-12-24